XML 118 R104.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidating Financial Information - Cash Flows (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 03, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Condensed Consolidating Statements Of Cash Flows        
Net cash provided by (used for) operating activities   $ 62,756 $ 531,905 $ 856,556
Cash flows from investing activities:        
Purchases of investments   (6,722) (24) (9)
Sales and maturities of investments   13,069 739 961
Proceeds from merger transaction       650,050
Cash paid for acquisitions of businesses, net of cash acquired   9,040 (22,278) (80,187)
Capital expenditures   (574,467) (395,455) (867,106)
Proceeds from sales of assets and insurance claims   57,933 34,831 68,206
Other   (856) 64 1,081
Investment in unconsolidated affiliates       (445)
Net cash (used for) provided by investing activities   (502,003) (382,123) (227,449)
Cash flows from financing activities:        
Increase (decrease) in cash overdrafts   (188) 3 645
Proceeds from issuance of long-term debt   411,200 600,000  
Debt issuance costs   (11,043) (11,520) (1,847)
Proceeds from revolving credit facilities   725,000 611,500 3,972
Reduction in revolving credit facilities   (215,000) (611,500) (450,000)
Proceeds from (payments for) issuance of common shares   8,300 967 1,296
Purchase of capped call hedge transactions   (40,250)    
Reduction of long-term debt   (381,814) (493,612) (27,478)
Dividends to shareholders $ (17,100) (68,503) (50,924) (69,363)
Proceeds from (payments for) commercial paper, net   40,000 (8,000) (525,119)
Payments on term loan   (162,500) (162,500) (300,000)
Proceeds from (payments for) short-term borrowings   (543) (6,211) 318
Cash proceeds from equity component of exchangeable debt   159,952    
Noncontrolling interest contribution   20,000   3,972
Distributions to noncontrolling interest   7,272    
Other changes   (8,211) (4,732) (7,767)
Proceeds from term loan       625,000
Repurchase of common shares   (18,071) (1,687) (99,598)
Redeemable noncontrolling interest contribution   61,123    
Net cash (used for) provided by financing activities   512,180 (138,216) (849,941)
Effect of exchange rate changes on cash and cash equivalents   (29) (2,003) (25,785)
Net increase (decrease) in cash and cash equivalents   72,904 9,563 (246,619)
Cash and cash equivalents, beginning of period   264,093 254,530 501,149
Cash and cash equivalents, end of period   336,997 264,093 254,530
Consolidating Adjustments        
Condensed Consolidating Statements Of Cash Flows        
Net cash provided by (used for) operating activities   (132,986) (50,423) (31,263)
Cash flows from investing activities:        
Cash paid for investments in consolidated affiliates     (245,459)  
Investment in unconsolidated affiliates   86,060    
Net cash (used for) provided by investing activities   86,060 245,459  
Cash flows from financing activities:        
Proceeds from parent contributions   (86,060) 245,458  
Dividends to shareholders   11,916 8,942 9,941
Distribution from subsidiary to parent   121,070 41,480 21,322
Net cash (used for) provided by financing activities   46,926 (195,036) 31,263
Parent Company | Reportable Legal Entities        
Condensed Consolidating Statements Of Cash Flows        
Net cash provided by (used for) operating activities   143,444 58,406 39,478
Cash flows from investing activities:        
Proceeds from merger transaction       5,500
Investment in unconsolidated affiliates   (100)    
Net cash (used for) provided by investing activities   (100)   5,500
Cash flows from financing activities:        
Proceeds from (payments for) issuance of common shares   8,299 967 1,296
Dividends to shareholders   (80,419) (59,866) (79,304)
Proceeds from issuance of intercompany debt   57,000 45,500  
Paydown of intercompany debt   (102,000) (40,000) (27,000)
Other changes   (8,210) (4,732) (7,767)
Repurchase of common shares   (18,071)    
Proceeds (issuance) of intercompany debt       67,500
Net cash (used for) provided by financing activities   (143,401) (58,131) (45,275)
Net increase (decrease) in cash and cash equivalents   (57) 275 (297)
Cash and cash equivalents, beginning of period   1,148 873 1,170
Cash and cash equivalents, end of period   1,091 1,148 873
Guarantor Subsidiaries | Reportable Legal Entities        
Condensed Consolidating Statements Of Cash Flows        
Net cash provided by (used for) operating activities   (90,229) (233,738) (217,685)
Cash flows from investing activities:        
Proceeds from merger transaction       646,078
Cash paid for investments in consolidated affiliates     86,459  
Change in intercompany balances   (599,974) (103,384) 135,518
Net cash (used for) provided by investing activities   (599,974) 16,925 781,596
Cash flows from financing activities:        
Proceeds from issuance of long-term debt   411,200 600,000  
Debt issuance costs   (11,043) (11,520) (1,847)
Proceeds from revolving credit facilities   725,000 610,000  
Reduction in revolving credit facilities   (215,000) (610,000) (450,000)
Proceeds from parent contributions   42,980 (159,000)  
Purchase of capped call hedge transactions   (40,250)    
Reduction of long-term debt   (270,269) (350,000)  
Proceeds from (payments for) commercial paper, net   40,000 (8,000) (525,119)
Payments on term loan   (162,500) (162,500) (300,000)
Cash proceeds from equity component of exchangeable debt   159,952    
Proceeds from issuance of intercompany debt   20,000    
Paydown of intercompany debt   (20,000)    
Proceeds from term loan       625,000
Proceeds (issuance) of intercompany debt       88,058
Net cash (used for) provided by financing activities   680,070 226,980 (563,908)
Net increase (decrease) in cash and cash equivalents   (10,133) 10,167 3
Cash and cash equivalents, beginning of period   10,177 10 7
Cash and cash equivalents, end of period   44 10,177 10
Other Subsidiaries (Non-Guarantors) | Reportable Legal Entities        
Condensed Consolidating Statements Of Cash Flows        
Net cash provided by (used for) operating activities   142,527 757,660 1,066,026
Cash flows from investing activities:        
Purchases of investments   (6,722) (24) (9)
Sales and maturities of investments   13,069 739 961
Proceeds from merger transaction       (1,528)
Cash paid for acquisitions of businesses, net of cash acquired   9,040 (22,278) (80,187)
Cash paid for investments in consolidated affiliates     159,000  
Capital expenditures   (574,467) (395,455) (867,106)
Proceeds from sales of assets and insurance claims   57,933 34,831 68,206
Change in intercompany balances   599,974 103,384 (135,518)
Other   (856) 64 1,081
Investment in unconsolidated affiliates   (85,960)   (445)
Net cash (used for) provided by investing activities   12,011 (644,507) (1,014,545)
Cash flows from financing activities:        
Increase (decrease) in cash overdrafts   (188) 3 645
Proceeds from revolving credit facilities     1,500 3,972
Reduction in revolving credit facilities     (1,500)  
Proceeds from parent contributions   43,080 (86,458)  
Proceeds from (payments for) issuance of common shares   1    
Reduction of long-term debt   (111,545) (143,612) (27,478)
Proceeds from (payments for) short-term borrowings   (543) (6,211) 318
Proceeds from issuance of intercompany debt   (77,000) (45,500)  
Noncontrolling interest contribution   20,000    
Paydown of intercompany debt   122,000 40,000 27,000
Distributions to noncontrolling interest   7,272    
Distribution from subsidiary to parent   (121,070) (41,480) (21,322)
Other changes   (1)    
Repurchase of common shares     (1,687) (99,598)
Redeemable noncontrolling interest contribution   61,123    
Proceeds (issuance) of intercompany debt       (155,558)
Net cash (used for) provided by financing activities   (71,415) (112,029) (272,021)
Effect of exchange rate changes on cash and cash equivalents   (29) (2,003) (25,785)
Net increase (decrease) in cash and cash equivalents   83,094 (879) (246,325)
Cash and cash equivalents, beginning of period   252,768 253,647 499,972
Cash and cash equivalents, end of period   $ 335,862 $ 252,768 $ 253,647